Top Markets
Coin of the day
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Rangering i aksjer #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Aksjekurs
$0.07600875
Sist synkronisert: 2024-11-20
Markedsverdi
$2.06M
Endring (1 dag)
-0.51%
Endring (1 år)
0.00%
Land
FR
Handel Quantum Genomics S.A. (ALQGC)

Kategori

Historikk for aksjesplitt for Quantum Genomics S.A. (ALQGC)
Aksjen Quantum Genomics S.A. (symbol: ALQGC) har gjennomgått totalt 1 aksjesplitt.
Den nyeste splittelsen skjedde Dec 13, 2013.
Én ALQGC-aksje kjøpt før Dec 13, 2013 tilsvarer i dag 0.055555555555556 ALQGC-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
2013-12-13 1:18 x0.055555555555556 x0.055555555555556
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE